Clinical Trial Update: Comtess® Versus Cabaseril® as Add-on to Levodopa in the Treatment of Parkinsonian Patients Suffering From Wearing- Off. [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Comtess (entacapone) versus Cabaseril (cabergoline) as add-ons to levodopa in Parkinson's disease patients with wearing-off; study compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Cabaseril (cabergoline)
• Comtess (entacapone)

Snippet

Sponsor: Orion Corporation, Orion Pharma | Conditions: Parkinson's Disease | Phase 4 | Status: COMPLETED